Judith Falloon

10.1k total citations · 1 hit paper
91 papers, 6.7k citations indexed

About

Judith Falloon is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Judith Falloon has authored 91 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Infectious Diseases, 37 papers in Epidemiology and 35 papers in Virology. Recurrent topics in Judith Falloon's work include HIV/AIDS drug development and treatment (38 papers), HIV Research and Treatment (35 papers) and HIV/AIDS Research and Interventions (22 papers). Judith Falloon is often cited by papers focused on HIV/AIDS drug development and treatment (38 papers), HIV Research and Treatment (35 papers) and HIV/AIDS Research and Interventions (22 papers). Judith Falloon collaborates with scholars based in United States, Spain and United Kingdom. Judith Falloon's co-authors include Henry Masur, H. Clifford Lane, Richard T. Davey, Joseph A. Kovacs, Julia A. Metcalf, Michael A. Polis, Robert Walker, Michael Baseler, Stephen C. Piscitelli and Robin Dewar and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Judith Falloon

91 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1999 639 citations Richard T. Davey, Julia A. Metcalf et al. profile →

Peers

Countries citing papers authored by Judith Falloon

Since Specialization

Citations

This map shows the geographic impact of Judith Falloon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Falloon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Falloon more than expected).

Fields of papers citing papers by Judith Falloon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Falloon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Falloon. The network helps show where Judith Falloon may publish in the future.

Co-authorship network of co-authors of Judith Falloon

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Falloon. A scholar is included among the top collaborators of Judith Falloon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Falloon. Judith Falloon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 12342: LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of the Anti-Endothelial Lipase Antibody MEDI5884 in Subjects With Stable CAD 2019 ·Circulation ·Christian T. Ruff, (unknown), Anton I. Rosenbaum, (unknown), (unknown), Sotirios K. Karathanasis, Judith Falloon, (unknown), (unknown), Judith Hsia, Boaz Hirshberg, Michael J. Koren, Marc S. Sabatine	1
2	Antibody and B cell responses to an investigational adjuvanted RSV vaccine for older adults 2019 ·Human Vaccines & Immunotherapeutics ·Adriana Weinberg, Stacie Lambert, Jennifer Canniff, Yu Li, Nancy Lang, Mark T. Esser, Judith Falloon, Myron J. Levin	4
3	Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation 2019 ·Value in Health ·Jing Yu, John H. Powers, (unknown), Judith Falloon	13
4	Quadrivalent Ann Arbor strain live-attenuated influenza vaccine 2012 ·Expert Review of Vaccines ·Seth Toback, Myron J. Levin, Stan L. Block, Robert B. Belshe, Christopher S. Ambrose, Judith Falloon	28
5	A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults 2011 ·Vaccine ·Stan L. Block, Tingting Yi, Eric Sheldon, Filip Dubovsky, Judith Falloon	50
6	Cryptococcosis and Idiopathic CD4 Lymphocytopenia 2007 ·Medicine ·Dimitrios Zonios, Judith Falloon, (unknown), Doreen Chaitt, John E. Bennett	74
7	A Randomized, Double‐Blinded, Placebo‐Controlled Trial of Intermittent Administration of Interleukin‐2 and Prednisone in Subjects Infected with Human Immunodeficiency Virus 2003 ·The Journal of Infectious Diseases ·Jorge A. Tavel, Irini Sereti, Robert Walker, Barbara Hahn, Joseph A. Kovacs, Shyla Jagannatha, Richard T. Davey, Judith Falloon, Michael A. Polis, Henry Masur, Julia A. Metcalf, Randy Stevens, Adam Rupert, Michael Baseler, H. Clifford Lane	12
8	Identification of Dynamically Distinct Subpopulations of T Lymphocytes That Are Differentially Affected by HIV 2001 ·The Journal of Experimental Medicine ·Joseph A. Kovacs, Richard A. Lempicki, Igor A. Sidorov, Joseph W. Adelsberger, Betsey Herpin, Julia A. Metcalf, Irini Sereti, Michael A. Polis, Richard T. Davey, Jorge A. Tavel, Judith Falloon, Randy Stevens, (unknown), Robin Dewar, Douglas J. Schwartzentruber, Miriam R. Anver, Michael Baseler, Henry Masur, Dimiter S. Dimitrov, H. Clifford Lane	181
9	Immunotherapy of HIV-Infected Patients with Intermittent Interleukin-2: Effects of Cycle Frequency and Cycle Duration on Degree of CD4+ T-Lymphocyte Expansion 2001 ·Clinical Immunology ·Kirk D. Miller, Katherine Spooner, Betsey Herpin, (unknown), (unknown), Richard T. Davey, Judith Falloon, Joseph A. Kovacs, Michael A. Polis, Robert Walker, Henry Masur, H. Clifford Lane	16
10	Effects of Intermittent Interleukin‐2 Therapy on Plasma and Tissue Human Immunodeficiency Virus Levels and Quasi‐Species Expression 2000 ·The Journal of Infectious Diseases ·Joseph A. Kovacs, Hiromi Imamichi, Susan Vogel, Julia A. Metcalf, Robin Dewar, Michael Baseler, Randy Stevens, Joseph W. Adelsberger, Laurie Lambert, Richard T. Davey, Robert Walker, Judith Falloon, Michael A. Polis, Henry Masur, H. Clifford Lane	25
11	Endocrine and Metabolic Evaluation of Human Immunodeficiency Virus-Infected Patients with Evidence of Protease Inhibitor-Associated Lipodystrophy 1999 ·The Journal of Clinical Endocrinology & Metabolism ·Jack A. Yanovski, Kirk D. Miller, Tomoshige Kino, Theodore C. Friedman, George P. Chrousos, Constantine Tsigos, Judith Falloon	122
12	Atovaquone Suspension in HIV‐Infected Volunteers: Pharmacokinetics, Pharmacodynamics, and TMP‐SMX Interaction Study 1999 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Judith Falloon, (unknown), Stephen C. Piscitelli, (unknown), Stephen W. LaFon, Brian M. Sadler, Robert Walker, Joseph A. Kovacs, Michael A. Polis, Richard T. Davey, H. Clifford Lane, Henry Masur	33
13	A Randomized Trial of High‐ versus Low‐Dose Subcutaneous Interleukin‐2 Outpatient Therapy for Early Human Immunodeficiency Virus Type 1 Infection 1999 ·The Journal of Infectious Diseases ·Richard T. Davey, Doreen Chaitt, Jeffrey M. Albert, Stephen C. Piscitelli, Joseph A. Kovacs, Robert Walker, Judith Falloon, Michael A. Polis, Julia A. Metcalf, Henry Masur, Robin Dewar, Michael Baseler, G. Fyfe, Martin Giedlin, H. Clifford Lane	112
14	HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies 1997 ·Nature Medicine ·Mark Connors, Joseph A. Kovacs, Seth Krevat, Juan Gea‐Banacloche, Michael C. Sneller, (unknown), Julia A. Metcalf, Robert Walker, Judith Falloon, Michael Baseler, Randy Stevens, Irwin M. Feuerstein, Henry Masur, H. Clifford Lane	430
15	Symptomatic appendiceal wall thickening in an HIV-infected patient caused by interleukin-2 therapy. 1997 ·American Journal of Roentgenology ·Nilo A. Avila, Andrew J. Dwyer, Judith Falloon	1
16	Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus 1996 ·New England Journal of Medicine ·Joseph A. Kovacs, Susan Vogel, Jeffrey M. Albert, Judith Falloon, Richard T. Davey, Robert Walker, Michael A. Polis, Katherine Spooner, (unknown), (unknown), G. Fyfe, H. C. Lane, Robin Dewar, Henry Masur	320
17	Inhibition of Immunoreactive Tumor Necrosis Factor- by a Chimeric Antibody in Patients Infected with Human Immunodeficiency Virus Type 1 1996 ·The Journal of Infectious Diseases ·Robert Walker, (unknown), Gerald D. Kelly, R. V. McCloskey, James N. Woody, Judith Falloon, Michael Baseler, Stephen C. Piscitelli, Richard T. Davey, Michael A. Polis, Joseph A. Kovacs, Henry Masur, H. Clifford Lane	60
18	Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160. 1993 ·Journal of Clinical Investigation ·Joseph A. Kovacs, M. B. Vasudevachari, (unknown), Richard T. Davey, Judith Falloon, Michael A. Polis, Julia A. Metcalf, Norman P. Salzman, Michael Baseler, Gale Smith	32
19	Human immunodeficiency virus infection in children 1989 ·The Journal of Pediatrics ·Judith Falloon, Janie Eddy, Lori Wiener, Philip A. Pizzo	165
20	Separation and function of neutrophil karyogranuloplasts and comparison with cytoplasts and intact cells 1987 ·Inflammation ·(unknown), Judith Falloon, Bruce Seligmann, Jayasree Nath, Marc M. Friedman, John I. Gallin	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact